BCL9 and ductal breast carcinoma in situ: As shown in Fig. 1j-k, PDX DCIS MIND models that showed invasive progression exhibited significantly higher nuclear BCL9/PS-727-STAT3 co-expression (Fig. 1j, k) compared to those that remained non-invasive.